university website

L. Katz (Lior), J.P. Gisbert (Javier), B. Manoogian (Beth), K. Lin (Kirk), C. Steenholdt (Casper), G.J. Mantzaris (Gerassimos ), A. Atreja (Ashish), Y. Ron (Yulia), A. Swaminath (Arun), S. Shah (Somal), et al. A. Hart (Ailsa), P.L. Lakatos (Peter), P. Ellul (Pierre), E. Israeli (Eran), M.N. Svendsen (Mads Naundrup), C.J. van der Woude (Janneke), K. Katsanos (Konstantinos), L. Yun (Laura), E.V. Tsianos (Epameinondas V.), T. Nathan (Torben), M. Abreu (Maria), I. Dotan (Iris), B. Lashner (Bret), J. Brynskov' (Jorn), J.P. Terdiman (Jonathan P.), P.D.R. Higgins, M. Chaparro (Maria) and S. Ben-Horin (Shomron)

2012-11-01

Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response

Publication

Publication

Inflammatory Bowel Diseases , Volume 18 - Issue 11 p. 2026- 2033

Additional Metadata
Keywords Crohn's disease, inflammatory bowel disease, infliximab
Persistent URL doi.org/10.1002/ibd.22902, hdl.handle.net/1765/89285
Journal Inflammatory Bowel Diseases
Organisation Erasmus MC: University Medical Center Rotterdam
Citation
Katz, L., Gisbert, J., Manoogian, B., Lin, K., Steenholdt, C., Mantzaris, G., Atreja, A., Ron, Y., Swaminath, A., Shah, S., Hart, A., Lakatos, P., Ellul, P., Israeli, E., Svendsen, M. N., van der Woude, J., Katsanos, K., Yun, L., Tsianos, E. V., … Ben-Horin, S. (2012). Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response. Inflammatory Bowel Diseases, 18(11), 2026–2033.https://doi.org/10.1002/ibd.22902


User Publication Person Organisation Collection
Close